首页> 外国专利> SUBSTANCE CAPABLE OF PREVENTING SUPPURATION AND AGGRAVATION BY DIRECT APPLICATION TO AFFECTED PART JUST AFTER SURGICAL OPERATION OR EXODONTIA OR EXPOSED AFFECTED PART OF EXTERNAL WOUND OR ATHLETE`S FOOT

SUBSTANCE CAPABLE OF PREVENTING SUPPURATION AND AGGRAVATION BY DIRECT APPLICATION TO AFFECTED PART JUST AFTER SURGICAL OPERATION OR EXODONTIA OR EXPOSED AFFECTED PART OF EXTERNAL WOUND OR ATHLETE`S FOOT

机译:在外科手术或牙结石手术或外伤或运动的足部暴露后,有能力通过直接施用于患部来预防补充和加重的物质

摘要

PURPOSE:A nonionic pharmaceutical, containing lysozyme as an active constituent, and capable of preventing the growth of bacteria by the direct application to an affected part or external wound just after the surgical operation or exodontia with no irritant action. CONSTITUTION:Lysozyme or lysozyme chloride is diluted with a carrier e.g. lactose, starch or a synthetic resin to about 5-10 times, and formulated into a pasty solution for use. The resultant pharmaceutical is directly applied to an affected part just after a surgical operation or exodontia or an exposed affected part of an external wound or athlete's foot to prevent the growth of bacteria. The treatment can be accelerated without showing the tendency to suppuration or aggravation. The substance is readily available and nontoxic to the human body even in a large amount.
机译:用途:一种非离子药物,含有溶菌酶作为活性成分,能够在手术后或牙髓外手术后立即直接施用于患处或外伤,而没有刺激作用,从而能够防止细菌生长。组成:溶菌酶或溶菌酶氯化物用载体稀释。乳糖,淀粉或合成树脂至约5-10倍,并配制成糊状溶液使用。刚进行外科手术或牙髓病或外伤或脚气的裸露患处后,即可将所得药物直接施用于患处,以防止细菌生长。可以加速治疗而不会出现化脓或加重的趋势。该物质易于获得,甚至对人体无毒。

著录项

  • 公开/公告号JPS5732226A

    专利类型

  • 公开/公告日1982-02-20

    原文格式PDF

  • 申请/专利权人 HITOMI SETSUO;

    申请/专利号JP19800106772

  • 发明设计人 SHIMIZU TETSUJI;

    申请日1980-08-05

  • 分类号A61K38/46;A61P1/02;

  • 国家 JP

  • 入库时间 2022-08-22 14:22:18

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号